On December 26, 2007, President Bush signed into law H.R. 2764, which gives the FDA nearly $1.73 billion in funding for fiscal 2008.
On December 26, 2007, President Bush signed into law H.R. 2764, which gives the FDA nearly $1.73 billion in funding for fiscal 2008.
As reported by FDA News, the bill gives the FDA more than $79 million above the president’s budget request and $145 million above the fiscal 2007 funding level. The Center for Drug Evaluation and Research (CDER) will receive more than $682 million, with $41.9 million of that going to the Office of Generic Drugs. The Center for Biologics Evaluation and Research (CBER) will receive more than $236 million.
Details on the bill can be seen at thomas.loc.gov/cgi-bin/bdquery/z?d110:h.r.02764,
FDANews report
Mastering Antibody-Drug Conjugates
December 19th 2024In this episode, we explore BIOVECTRA’s capabilities in antibody-drug conjugate (ADC) manufacturing, from complex conjugation chemistry to synthesis of highly potent payloads. We’ll also showcase how BIOVECTRA’s extensive experience in complex chemistries and specialized small molecule manufacturing gives them a unique perspective, strengthening their approach to ADC production and ensuring clients receive custom solutions across all project stages.